Your browser doesn't support javascript.
loading
Concordance in judgment of clinical borders of basal cell carcinomas in Japanese patients: A preliminary study of JCOG2005 (J-BASE-MARGIN).
Kamimura, Anna; Nakamura, Yasuhiro; Takenouchi, Tatsuya; Matsushita, Shigeto; Omodaka, Toshikazu; Yamamura, Kentaro; Uchi, Hiroshi; Yoshikawa, Shusuke; Yanagisawa, Hiroto; Ito, Takamichi; Kiyohara, Yoshio; Nakamura, Yoshio; Aoki, Megumi; Ishizuki, Shoichiro; Oashi, Kohei; Miyagawa, Takuya; Maeda, Taku; Ogata, Dai; Hatta, Naohito; Ohe, Shuichi; Isei, Taiki; Takahashi, Akira; Umeda, Yoshiyasu; Yamaguchi, Buntaro; Ishikawa, Masashi; Horimoto, Kohei; Fujsawa, Yasuhiro; Uehara, Jiro; Shibayama, Yoshitsugu; Kiniwa, Yukiko; Kawahara, Yu; Matsuya, Taisuke; Uhara, Hisashi; Kato, Junji; Nakamura, Yoshiyuki; Murakami, Takuo; Namikawa, Kenjiro; Yoshino, Koji; Funakoshi, Takeru; Takatsuka, Sumiko; Matsui, Yu; Sasaki, Jin; Koga, Hiroshi; Yokota, Kenji; Komori, Takaya; Fukushima, Satoshi; Yamazaki, Naoya.
Affiliation
  • Kamimura A; Department of Skin Oncology/Dermatology, Saitama Medical University International Medical Center, Saitama, Japan.
  • Nakamura Y; Department of Skin Oncology/Dermatology, Saitama Medical University International Medical Center, Saitama, Japan.
  • Takenouchi T; Department of Dermatology, Niigata Cancer Center, Niigata, Japan.
  • Matsushita S; Department of Dermato-Oncology/Dermatology, National Hospital Organization Kagoshima Medical Center, Kagoshima, Japan.
  • Omodaka T; Department of Dermatology, Shinshu University, Matsumoto, Japan.
  • Yamamura K; Department of Dermato-Oncology/Dermatology, National Hospital Organization Kagoshima Medical Center, Kagoshima, Japan.
  • Uchi H; Department of Dermatologic Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Yoshikawa S; Dermatology Division, Shizuoka Cancer Center, Shizuoka, Japan.
  • Yanagisawa H; Department of Dermatology, Saitama Medical University, Saitama, Japan.
  • Ito T; Department of Dermatology, Kyushu University, Fukuoka, Japan.
  • Kiyohara Y; Dermatology Division, Shizuoka Cancer Center, Shizuoka, Japan.
  • Nakamura Y; Department of Dermatology, Keio University, Tokyo, Japan.
  • Aoki M; Department of Dermato-Oncology/Dermatology, National Hospital Organization Kagoshima Medical Center, Kagoshima, Japan.
  • Ishizuki S; Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Oashi K; Department of Dermatology, Saitama Cancer Center, Saitama, Japan.
  • Miyagawa T; Department of Dermatology, University of Tokyo, Tokyo, Japan.
  • Maeda T; Department of Plastic and Reconstructive Surgery, Hokkaido University, Sapporo, Japan.
  • Ogata D; Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Hatta N; Department of Dermatology, Toyama Prefectural Central Hospital, Toyama, Japan.
  • Ohe S; Department of Dermatologic Oncology, Osaka International Cancer Institute, Osaka, Japan.
  • Isei T; Department of Dermatologic Oncology, Osaka International Cancer Institute, Osaka, Japan.
  • Takahashi A; Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Umeda Y; Department of Skin Oncology/Dermatology, Saitama Medical University International Medical Center, Saitama, Japan.
  • Yamaguchi B; Department of Skin Oncology/Dermatology, Saitama Medical University International Medical Center, Saitama, Japan.
  • Ishikawa M; Department of Dermatology, Saitama Cancer Center, Saitama, Japan.
  • Horimoto K; Department of Dermatology, Sapporo Medical University Hospital, Sapporo, Japan.
  • Fujsawa Y; Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Uehara J; Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
  • Shibayama Y; Department of Dermatology, Fukuoka University, Fukuoka, Japan.
  • Kiniwa Y; Department of Dermatology, Shinshu University, Matsumoto, Japan.
  • Kawahara Y; Department of Skin Oncology/Dermatology, Saitama Medical University International Medical Center, Saitama, Japan.
  • Matsuya T; Department of Dermatology, Asahikawa Medical University, Asahikawa, Japan.
  • Uhara H; Department of Dermatology, Sapporo Medical University Hospital, Sapporo, Japan.
  • Kato J; Department of Dermatology, Sapporo Medical University Hospital, Sapporo, Japan.
  • Nakamura Y; Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Murakami T; Department of Dermatology, Saitama Medical University, Saitama, Japan.
  • Namikawa K; Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Yoshino K; Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
  • Funakoshi T; Department of Dermatology, Keio University, Tokyo, Japan.
  • Takatsuka S; Department of Dermatology, Niigata Cancer Center, Niigata, Japan.
  • Matsui Y; Department of Dermatology, Niigata Cancer Center, Niigata, Japan.
  • Sasaki J; Department of Dermatology, Niigata Cancer Center, Niigata, Japan.
  • Koga H; Department of Dermatology, Shinshu University, Matsumoto, Japan.
  • Yokota K; Department of Dermatology, Nagoya University, Nagoya, Japan.
  • Komori T; Department of Dermatology, Kyoto University, Kyoto, Japan.
  • Fukushima S; Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
  • Yamazaki N; Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan.
J Dermatol ; 49(9): 837-844, 2022 Sep.
Article in En | MEDLINE | ID: mdl-35510662
ABSTRACT
Basal cell carcinoma is the most common type of skin cancer, and surgical excision with clear margins is the standard of care. Surgical margins are determined based on risk factors (high or low risk) for recurrence according to the National Comprehensive Cancer Network and Japanese basal cell carcinoma guidelines. The clarity of the clinical tumor border (well-defined or poorly defined) is considered a risk factor, and significant discrepancies in the judgment of clinical tumor borders among dermato-oncologists may occur. Therefore, we analyzed the dermato-oncologists' concordance in judging the clinical tumor border of basal cell carcinoma. Forty-seven dermato-oncologists (experts 37; young trainees 10) participated in this study. The datasets of clinical and dermoscopic photographs of 79 Japanese cases of head and neck basal cell carcinoma were used to determine the concordance in the judgment of clinical tumor border. The probability of the border that was selected more often was used to calculate the rater agreement rate for each dataset. Correct judgment was defined as a more frequently selected border, and the concordance rate of clarity of clinical tumor border for each dermato-oncologist was calculated based on the definition of the correct judgment. A median concordance rate of 85% or higher for all dermato-oncologists was predefined as an acceptable rate for clinical use. Of the 79 datasets, rater agreement rates were 80-100%, 60-79%, and 51-59% for 55, 19, and five datasets, respectively. The median concordance rate for all dermato-oncologists was 86% (interquartile range 82-89%). There was no significant difference in the concordance rate between the experts and the trainees (median, 87% vs. 85.5%; p = 0.58). The concordance rates of dermato-oncologists for all datasets were relatively high and acceptable for clinical use.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Carcinoma, Basal Cell / Head and Neck Neoplasms Type of study: Diagnostic_studies / Guideline Limits: Humans Country/Region as subject: Asia Language: En Journal: J Dermatol Year: 2022 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Carcinoma, Basal Cell / Head and Neck Neoplasms Type of study: Diagnostic_studies / Guideline Limits: Humans Country/Region as subject: Asia Language: En Journal: J Dermatol Year: 2022 Document type: Article Affiliation country: